1. Home
  2. PED vs PSNL Comparison

PED vs PSNL Comparison

Compare PED & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pedevco Corp.

PED

Pedevco Corp.

HOLD

Current Price

$0.55

Market Cap

53.5M

Sector

Energy

ML Signal

HOLD

Logo Personalis Inc.

PSNL

Personalis Inc.

HOLD

Current Price

$7.81

Market Cap

746.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PED
PSNL
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5M
746.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PED
PSNL
Price
$0.55
$7.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$1.50
$10.71
AVG Volume (30 Days)
152.3K
1.4M
Earning Date
11-17-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
156.43
N/A
EPS
0.11
N/A
Revenue
$33,244,999.00
$69,103,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$305.89
$20.33
P/E Ratio
$5.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$2.83
52 Week High
$1.00
$11.40

Technical Indicators

Market Signals
Indicator
PED
PSNL
Relative Strength Index (RSI) 52.38 40.26
Support Level $0.54 $7.88
Resistance Level $0.58 $9.10
Average True Range (ATR) 0.04 0.47
MACD 0.00 -0.09
Stochastic Oscillator 68.93 5.26

Price Performance

Historical Comparison
PED
PSNL

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: